The FDA has granted Fast Track designation to pevifoscorvir sodium, an oral capsid assembly modulator for chronic HBV.
Establishing an innovative class of polyomavirus antivirals spanning BK and JC virus indications CANTON, Mass.--(BUSINESS ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced that Astellas Pharma Inc. (TSE: ...
A collaborative research team led by Kazuyoshi Murata determined the capsid structure of the giant Melbournevirus at 4.4 Å resolution using cryo-electron microscopy. By applying a block-based ...
Dyno Therapeutics, a privately-held US genetic technologies company applying artificial intelligence (AI) to solve the grand ...
Received FDA Fast Track Designation for pevifoscorvir sodium for the treatment of chronic hepatitis B virus infectionHBeAg- cohort sample size ...
The 12 pentagonal vertices (two of which are shown in the diagram) are composed of protein components designated as Penton (black), PC-α (magenta), PC-β (green), and PC-γ (blue). The 20 triangular ...
Aligos to receive an upfront payment of $25M USDUp to $420M USD in clinical, regulatory, and sales milestones along with tiered, high ...
Pharmaceutical Technology on MSN
Aligos and Xiamen Amoytop sign deal for HBV therapy
Aligos remains eligible for up to $420m in milestones and tiered, high single-digit royalties on Amoytop’s net sales.
Genome‑wide CRISPR screens in primary human T cells reveal human genes that promote or block HIV infection, uncovering potent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results